Cardiac marker quality control serum preparation method
The invention discloses a cardiac marker quality control serum preparation method. Normal human serum is adopted as a substrate liquid, impurities are removed by a filter membrane after a warm bath for 1 to 3 hours, CK, CK-MB, cTnI, cTnT, CRP, BNP, MYO, NT-proBNP, HCY, H-FABP, Dig and other cardiac...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a cardiac marker quality control serum preparation method. Normal human serum is adopted as a substrate liquid, impurities are removed by a filter membrane after a warm bath for 1 to 3 hours, CK, CK-MB, cTnI, cTnT, CRP, BNP, MYO, NT-proBNP, HCY, H-FABP, Dig and other cardiac marker positive substances are added to the obtained quality control serum substrate liquid, qualitycontrol serum solutions with a high, a medium and a low concentration level are prepared, a proper amount of preservative, a protein protective agent and a stabilizer are added and are then mixed uniformly, debugging and determining are carried out, and after the detected result meets a quality standard, the solution is placed in a glass bottle for low temperature vacuum drying to be in a freeze-dried state and is saved at 2 to 8 DEH C. The quality control serum selects normal human serum/normal human plasma/de-hormone human serum/delipidated human serum as the substrate liquid, and the stable-performance multi-item |
---|